SavedAdd your journal

Journals / Türkiye Acil Tıp Dergisi / 2009 / Cilt: 9 - Sayı: 4

Bioterrorism and anthrax

Biyoterorizm ve şarbon

Mustafa SERİNKEM
Sayın Selda KUTLU
Pages
185–190
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This paper gives succinct information about bioterrorism and anthrax, which is considered among the biological weapons used in bioterrorism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bioterrorism is described as the intentional dissemination of biological agents by people, groups or governments among people, animals and plants in order to develop an illness or to kill with the purpose of obtaining ideological, political, religious or economical gains.
📊
Key Findings & Data:Emergency departments are the places that are most likely affected from such attacks while treating victims.
💡
Conclusion & Impact:This paper gives succinct information about bioterrorism and anthrax, which is considered among the biological weapons used in bioterrorism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bioterrorism is described as the intentional dissemination of biological agents by people, groups or governments among people, animals and plants in order to develop an illness or to kill with the purpose of obtaining ideological, political, religious or economical gains. Emergency departments are the places that are most likely affected from such attacks while treating victims. Therefore, physicians in the emergency departments should be well-informed about the agents used in bioterrorism and the possible symptoms they cause. This paper gives succinct information about bioterrorism and anthrax, which is considered among the biological weapons used in bioterrorism.

Özet

Biyoterörizm kişiler, gruplar veya hükümetler tarafından ideolojik, politik, dini veya ekonomik kazanç sağlamak amacıyla biyolojik ajanların insanlarda, hayvanlarda ve bitkilerde hastalık oluşturmak ve/veya ölüme neden olmak amacıyla kullanılması olarak tanımlanmaktadır. Acil servisler, hastalara müdahale sürecinde bu tür saldırılardan en çok etkilenecek birimlerdir. Acil servis hekimlerininde, biyoterorizmde kullanılan ajanlar ve neden olduğu semptomlar hakkında bilgili olmaları gerekir. Bu yazı, biyoterorizm ve biyoterorizmde sık kullanılan biyolojik silahlar arasında yer alan şarbon hakkında özet bilgiler içermektedir.

🔖

Cite This Article

SERİNKEM, M., KUTLU, S. S. (2022). Bioterrorism and anthrax. Türkiye Acil Tıp Dergisi, Cilt: 9 - Sayı: 4, 185–190. https://ajindex.com/articles/626087

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Klietmann WF, Ruoff KL. Bioterrorism: implications for the clinical microbiologist. Clin MicrobiolRev 2001
  2. 14(2):364-81. 2.Venkatesh S, Memish ZA. Bioterrorism-a new challenge for public health. Int JAntimicrob Agents 2003
  3. 21(2):200-6. 3.Leggiadro RJ. The threat of biological terrorism: a public health and infection control reality. Infect Control Hosp Epidemiol 2000
  4. 21(l):53-6. 4.WHO. Health aspects of chemical and biological weapons. Geneva: WHO
  5. Karwa M, Currie B, Kvetan V. Bioterrorism: Preparing for the impossible or the improbable. Crit Care Med 2005
  6. 33(l Suppl):S75-95. 6.Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS. Bacterial pathogens as biological weapons and agents of bioterrorism. Am JMedSci 2002
  7. 323(6):299-315. 7.Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Xnthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002
  8. 287(17):2236-52. 8.Baysallar M. Olağanüstü durumlarda DAS yönetimi.iyoter-örizm. 5. Ulusal Sterilizasyon Dezenfeksiyon Kongresi Bildiri Kitabı
  9. s. 521-39. 9.Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, et al. Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis. Euro Surveill 2004
  10. 9(12):E15-6. 10.Schmid G, Kaufmann A. Anthrax in Europe: its epidemiology, clinical characteristics, and role in bioterrorism. Clin Microbiol Infect 2002
  11. 8(8):479-88. 11.Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994
  12. 266(5188): 1202-8. 12.Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001
  13. 7(6):933-44. 13.Friedlander AM, Welkos SL, Pitt ML, Ezzell JW, Worsham PL, Rose KJ, et al. Postexposure prophylaxis against experimental v inhalation anthrax. J Infect Dis 1993
  14. 167(5):1239-43. 14.Peters CJ, Hartley DM. Anthrax inhalation and lethal human infection. Lancet 2002
  15. 359(9307):710-l. 15.Navas E. Problems associated with potential massive use of antimicrobial agents as prophylaxis or therapy of a bioterrorist attack. Clin Microbiol Infect 2002
  16. 8(8):534-9. 16.Bell DM, Kozarsky PE, Stephens DS. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 2002
  17. 8(2):222-5. 17.Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR,